Abstract
Purpose
Cutibacterium spp. (formerly Propionibacterium) is a slow growing, Gram-positive, anaerobic bacteria and is an emerging clinical entity in prosthetic joint infection (PJI). This study compares the presentation, surgical management, and post-operative antibiotic therapy of patients with positive intraoperative cultures during revision total joint arthroplasty (TJA) of the hip, knee, and shoulder.
Methods
This was a retrospective cohort study of patients from 2014 to 2020 of 57 revision TJAs (27 total hip arthroplasty (THA), 17 total shoulder arthroplasty (TSA), and 13 total knee arthroplasty (TKA)) with intraoperative cultures positive for Cutibacterium at a tertiary academic centre. Patient demographics, pre-operative labs, radiographs, and aspirate results were collected. Intraoperative data was reviewed. Post-operative antibiotic therapy and repeat infections were recorded. Data was compared with univariate analyses.
Results
There was no significant difference in pre-operative lab values between the cohorts. All cohorts had > 58% radiographic lucency. Revision TSA patients had significantly fewer pre-operative aspirates. Six patients undergoing revision THA, three TKA and one TSA had a repeat infection requiring further surgery. Four in the THA cohort and one in the TKA cohort with repeat infections did not receive prolonged antibiotic therapy.
Conclusion
Cutibacterium is an infectious agent that can present in an indolent fashion after TJA. It commonly causes progressive radiographic lucency. The workup and post-operative management differs in the hip, knee, and shoulder, which is likely due to existing literature guiding physician practice. In all joints, Cutibacterium is a virulent pathogen that can cause repeat infections requiring surgical treatment.
Similar content being viewed by others
Data availability
This is not applicable.
Code availability
This is not applicable.
References
Kremers HM, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA, Jiranek WA, Berry DJ (2015) Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 97(17):1386. https://doi.org/10.2106/JBJS.N.01141
Singh JA, Yu S, Chen L, Cleveland JD (2019) Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol 46(9):1134–40. https://doi.org/10.3899/jrheum.170990
Namba RS, Inacio MC, Paxton EW (2013) Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg 95(9):775–82. https://doi.org/10.2106/JBJS.L.00211
Edwards JR, Peterson KD, Mu Y, Banerjee S, Allen-Bridson K, Morrell G, Dudeck MA, Pollock DA, Horan TC (2009) National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 37(10):783–805. https://doi.org/10.1016/j.ajic.2009.10.001
Kurtz SM, Ong KL, Schmier J, Mowat F, Saleh K, Dybvik E, Kärrholm J, Garellick G, Havelin LI, Furnes O, Malchau H (2007) Future clinical and economic impact of revision total hip and knee arthroplasty. J Bone Joint Surg 89(suppl_3):144–51. https://doi.org/10.2106/JBJS.G.00587
Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J (2009) Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 24(6):105–9. https://doi.org/10.1016/j.arth.2009.04.027
Mariconda M, Ascione T, Balato G, Rotondo R, Smeraglia F, Costa GG, Conte M (2013) Sonication of antibiotic-loaded cement spacers in a two-stage revision protocol for infected joint arthroplasty. BMC Musculoskelet Disord 14(1):1–8. https://doi.org/10.1186/1471-2474-14-193
Kim YS, Bae KC, Cho CH, Lee KJ, Sohn ES, Kim BS (2013) Two-stage revision using a modified articulating spacer in infected total knee arthroplasty. Knee Surg Relat Res 25(4):180. https://doi.org/10.5792/ksrr.2013.25.4.180
Hsu YH, Hu CC, Hsieh PH, Shih HN, Ueng SW, Chang Y (2017) Vancomycin and ceftazidime in bone cement as a potentially effective treatment for knee periprosthetic joint infection. J Bone Joint Surg 99(3):223–31. https://doi.org/10.2106/JBJS.16.00290
Corvec S (2018) Clinical and biological features of Cutibacterium (formerly Propionibacterium) avidum, an underrecognized microorganism. Clin Microbiol Rev 31(3):e00064-17. https://doi.org/10.1128/CMR.00064-17
Scholz CF, Kilian M (2016) The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacterium gen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol 66(11):4422–32. https://doi.org/10.1099/ijsem.0.001367
Sampedro MF, Piper KE, McDowell A, Patrick S, Mandrekar JN, Rouse MS, Steckelberg JM, Patel R (2009) Species of Propionibacterium and Propionibacterium acnes phylotypes associated with orthopedic implants. Diagn Microbiol Infect Dis 64(2):138–45. https://doi.org/10.1016/j.diagmicrobio
Lavergne V, Malo M, Gaudelli C, Laprade M, Leduc S, Laflamme P, Rouleau DM (2017) Clinical impact of positive Propionibacterium acnes cultures in orthopedic surgery. Orthop Traumatol: Surgery & Research 103(2):307–14. https://doi.org/10.1016/j.otsr.2016.12.005
Portillo ME, Corvec S, Borens O, Trampuz A (2013) Propionibacterium acnes: an underestimated pathogen in implant-associated infections. BioMed Res Int 2013:804391. https://doi.org/10.1155/2013/804391
Dodson CC, Craig EV, Cordasco FA, Dines DM, Dines JS, DiCarlo E, Brause BD, Warren RF (2010) Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. J Shoulder Elbow Surg 19(2):303–7. https://doi.org/10.1016/j.jse.2009.07.065
Hudek R, Sommer F, Kerwat M, Abdelkawi AF, Loos F, Gohlke F (2014) Propionibacterium acnes in shoulder surgery: true infection, contamination, or commensal of the deep tissue? J Shoulder Elbow Surg 23(12):1763–71. https://doi.org/10.1016/j.jse.2014.05.024
Nodzo SR, Westrich GH, Henry MW, Miller AO (2016) Clinical analysis of Propionibacterium acnes infection after total knee arthroplasty. J Arthroplasty 31(9):1986–9. https://doi.org/10.1016/j.arth.2016.02.025
Zeller VA, Letembet VA, Meyssonnier VA, Heym B, Ziza JM, Marmor SD (2018) Cutibacterium (formerly Propionibacterium) avidum: a rare but avid agent of prosthetic hip infection. J Arthroplasty 33(7):2246–50. https://doi.org/10.1016/j.arth.2018.02.008
Achermann Y, Liu J, Zbinden R, Zingg PO, Anagnostopoulos A, Barnard E, Sutter R, Li H, McDowell A, Zinkernagel AS (2018) Propionibacterium avidum: a virulent pathogen causing hip periprosthetic joint infection. Clin Infect Dis 66(1):54–63. https://doi.org/10.1093/cid/cix665
Pottinger P, Butler-Wu S, Neradilek MB, Merritt A, Bertelsen A, Jette JL, Warme WJ, Matsen FA III (2012) Prognostic factors for bacterial cultures positive for Propionibacterium acnes and other organisms in a large series of revision shoulder arthroplasties performed for stiffness, pain, or loosening. JBJS 94(22):2075–83. https://doi.org/10.2106/JBJS.K.00861
Garrigues GE, Zmistowski B, Cooper AM, Green A, Abboud J, Beazley J, Bozhkova S, Brandao P, Chen A, Choon D, Cil A (2019) Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: evaluation of periprosthetic shoulder infection. J Shoulder Elbow Surg 28(6):S32-66. https://doi.org/10.1016/j.jse.2019.04.016
Hecker A, Jungwirth-Weinberger A, Bauer MR, Tondelli T, Uçkay I, Wieser K (2020) The accuracy of joint aspiration for the diagnosis of shoulder infections. J Shoulder Elbow Surg 29(3):516–20. https://doi.org/10.1016/j.jse.2019.07.016
Contreras ES, Frantz TL, Bishop JY, Cvetanovich GL (2020) Periprosthetic infection after reverse shoulder arthroplasty: a review. Curr Rev Musculoskelet Med 1-2
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2013) Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56(1):1–10. https://doi.org/10.1093/cid/cis966
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Niall Cochrane, Billy Kim, Patrick Kelly, and Jessica Seidelman. The first draft of the manuscript was written by Niall Cochrane, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
This is a retrospective cohort study that was approved by the Duke University Institutional Review Board.
Consent to participate
This is not applicable.
Competing interests
Authors Niall Cochrane, Billy Kim, Patrick Kelly and Jessica Seidelman have no relevant financial or nonfinancial interests to disclose. William Jiranek has stock options in Biomech LLC and receives royalties from Depuy. Dr. Jiranek is also an active member of the Hip Society and American Association of Hip and Knee Surgeons. Dr. Seyler receives royalties from Total Joint Orthopedics, Inc., Pattern Health and Restor3d. He is a paid consultant for Smith and Nephew, Total Joint Orthopedics, Inc. and Heraeus, He receives research support from Next Science and Zimmer and financial material support from Lippincott Williams and Wilkins. He is an active member of the American Association of Hip and Knee Surgeons and the Musculoskeletal Infection Society. Dr. Klifto is a paid consultant for Integra and Additive Orthopedics. He gives paid presentations for Integra. He has stock options in GE Healthcare, Johnson and Johnson, Merck, and Pfizer.
Disclosure
Institution at which work was performed: Duke University Medical Center.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cochrane, N., Kim, B., Kelly, P. et al. Cutibacterium positive cultures in total joint arthroplasty: a comparison of the hip, knee, and shoulder. International Orthopaedics (SICOT) 47, 1939–1946 (2023). https://doi.org/10.1007/s00264-023-05804-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-023-05804-y